Lobe Sciences Ltd. (LOBE.CN)
CAD 0.02
(-42.86%)
CAD 0.02
(-42.86%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.29 Million CAD | 31.57% |
| 2022 | 1.74 Million CAD | -85.55% |
| 2021 | 12.09 Million CAD | -6.73% |
| 2020 | 12.97 Million CAD | 92.99% |
| 2019 | 6.72 Million CAD | 90261.28% |
| 2018 | 7438.00 CAD | -75.42% |
| 2017 | 30.26 Thousand CAD | -13.28% |
| 2016 | 34.9 Thousand CAD | -61.43% |
| 2015 | 90.47 Thousand CAD | -64.54% |
| 2014 | 255.15 Thousand CAD | -29.32% |
| 2013 | 361.01 Thousand CAD | -25.94% |
| 2012 | 487.48 Thousand CAD | 164.94% |
| 2011 | 183.99 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.18 Million CAD | -4.77% |
| 2024 Q3 | 1.96 Million CAD | -7.02% |
| 2024 Q2 | 2.1 Million CAD | -3.7% |
| 2023 Q1 | 1.49 Million CAD | -14.24% |
| 2023 Q2 | 1.17 Million CAD | -21.8% |
| 2023 Q4 | 2.29 Million CAD | -38.23% |
| 2023 Q3 | 3.72 Million CAD | 217.66% |
| 2023 FY | 2.29 Million CAD | 31.57% |
| 2022 FY | 1.74 Million CAD | -85.55% |
| 2022 Q1 | 7.97 Million CAD | -34.08% |
| 2022 Q4 | 1.74 Million CAD | -47.39% |
| 2022 Q3 | 3.32 Million CAD | -36.22% |
| 2022 Q2 | 5.2 Million CAD | -34.69% |
| 2021 Q2 | 14.13 Million CAD | 9.43% |
| 2021 Q3 | 28.83 Million CAD | 104.03% |
| 2021 FY | 12.09 Million CAD | -6.73% |
| 2021 Q4 | 12.09 Million CAD | -58.04% |
| 2021 Q1 | 12.91 Million CAD | -0.45% |
| 2020 Q1 | 6.75 Million CAD | 0.57% |
| 2020 FY | 12.97 Million CAD | 92.99% |
| 2020 Q2 | 6.42 Million CAD | -4.9% |
| 2020 Q4 | 12.97 Million CAD | 103.91% |
| 2020 Q3 | 6.36 Million CAD | -1.04% |
| 2019 Q2 | 4852.00 CAD | -34.77% |
| 2019 FY | 6.72 Million CAD | 90261.28% |
| 2019 Q3 | 7.17 Million CAD | 147699.9% |
| 2019 Q4 | 6.72 Million CAD | -6.28% |
| 2019 Q1 | 7438.00 CAD | 55.7% |
| 2018 Q2 | 19.02 Thousand CAD | -37.14% |
| 2018 Q1 | 30.26 Thousand CAD | -30.31% |
| 2018 FY | 7438.00 CAD | -75.42% |
| 2018 Q3 | 10.56 Thousand CAD | -44.49% |
| 2018 Q4 | 4777.00 CAD | -54.77% |
| 2017 Q4 | 43.42 Thousand CAD | -26.68% |
| 2017 FY | 30.26 Thousand CAD | -13.28% |
| 2017 Q3 | 59.23 Thousand CAD | -21.59% |
| 2017 Q2 | 75.54 Thousand CAD | 116.45% |
| 2017 Q1 | 34.9 Thousand CAD | -33.21% |
| 2016 FY | 34.9 Thousand CAD | -61.43% |
| 2016 Q2 | 81.92 Thousand CAD | -9.46% |
| 2016 Q4 | 52.25 Thousand CAD | -21.83% |
| 2016 Q3 | 66.84 Thousand CAD | -18.41% |
| 2016 Q1 | 90.47 Thousand CAD | -56.67% |
| 2015 FY | 90.47 Thousand CAD | -64.54% |
| 2015 Q4 | 208.8 Thousand CAD | -6.54% |
| 2015 Q3 | 223.4 Thousand CAD | -5.86% |
| 2015 Q2 | 237.32 Thousand CAD | -6.99% |
| 2015 Q1 | 255.15 Thousand CAD | -6.48% |
| 2014 Q3 | 304.55 Thousand CAD | -9.72% |
| 2014 Q1 | 361.01 Thousand CAD | -7.34% |
| 2014 FY | 255.15 Thousand CAD | -29.32% |
| 2014 Q2 | 337.33 Thousand CAD | -6.56% |
| 2014 Q4 | 272.84 Thousand CAD | -10.41% |
| 2013 Q3 | 424.99 Thousand CAD | -8.21% |
| 2013 Q1 | 487.48 Thousand CAD | -1.68% |
| 2013 Q2 | 463.02 Thousand CAD | -5.02% |
| 2013 Q4 | 389.61 Thousand CAD | -8.32% |
| 2013 FY | 361.01 Thousand CAD | -25.94% |
| 2012 Q2 | 157.94 Thousand CAD | -14.16% |
| 2012 FY | 487.48 Thousand CAD | 164.94% |
| 2012 Q1 | 183.99 Thousand CAD | 0.0% |
| 2012 Q3 | 543.1 Thousand CAD | 243.86% |
| 2012 Q4 | 495.82 Thousand CAD | -8.71% |
| 2011 FY | 183.99 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aion Therapeutic Inc. | 210.67 Thousand CAD | -991.503% |
| Ayurcann Holdings Corp. | 14.85 Million CAD | 84.519% |
| Blueberries Medical Corp. | 2.41 Million CAD | 4.849% |
| The BC Bud Corporation | 632.06 Thousand CAD | -263.806% |
| BioNxt Solutions Inc. | 1.26 Million CAD | -81.411% |
| CordovaCann Corp. | 10.26 Million CAD | 77.596% |
| Christina Lake Cannabis Corp. | 15.96 Million CAD | 85.594% |
| Captor Capital Corp. | 33.85 Million CAD | 93.208% |
| City View Green Holdings Inc. | 3846.00 CAD | -59689.158% |
| 1CM Inc. | 34.01 Million CAD | 93.241% |
| Global Hemp Group Inc. | 42.76 Thousand CAD | -5277.543% |
| Greenway Greenhouse Cannabis Corporation | 33.08 Million CAD | 93.051% |
| IM Cannabis Corp. | 48.81 Million CAD | 95.289% |
| Maple Leaf Green World Inc. | 168.27 Thousand CAD | -1266.524% |
| Mountain Valley MD Holdings Inc. | 8.96 Million CAD | 74.353% |
| Nextleaf Solutions Ltd. | 8.53 Million CAD | 73.065% |
| Ovation Science Inc. | 76.88 Thousand CAD | -2890.702% |
| Pharmadrug Inc. | 1.45 Million CAD | -57.533% |
| Captiva Verde Wellness Corp. | 9.1 Million CAD | 74.737% |
| RAMM Pharma Corp. | 32.3 Million CAD | 92.881% |
| RIV Capital Inc. | 1.74 Million CAD | -32.113% |
| Revive Therapeutics Ltd. | 10.63 Million CAD | 78.38% |
| Red White & Bloom Brands Inc. | 234.25 Million CAD | 99.018% |
| SLANG Worldwide Inc. | 33.2 Million CAD | 93.074% |
| 1933 Industries Inc. | 18.01 Million CAD | 87.239% |
| Red Light Holland Corp. | 24.08 Million CAD | 90.452% |
| Top Strike Resources Corp. | 11.73 Million CAD | 80.405% |
| Xebra Brands Ltd. | 379.36 Thousand CAD | -506.137% |
| Adastra Holdings Ltd. | 32.34 Million CAD | 92.89% |